SUBSCRIBE
SUBSCRIBE

Postmarket research

Drug Development
Gene Variations May Predict Antidepressant Response, Mayo Clinic Study Finds
July 21, 2008
 · 
1 min read
Drug Development
Drug Restores Speech in Alzheimer’s in Institute For Neurological Research Study; Experts Worry
July 21, 2008
 · 
1 min read
Drug Development
Epilepsy Drug Eases Diabetic Neuropathy Pain in Harvard Medical School Study
July 18, 2008
 · 
1 min read
Drug Development
Imperial College London Scientists Say Arthritis Wonder Drugs Could Provide Clues for All Disease
July 18, 2008
 · 
1 min read
Drug Development
Analgesic Drugs Don’t Reduce Ovarian Cancer Risk, Fred Hutchinson Cancer Research Center Study Finds
July 18, 2008
 · 
1 min read
Drug Development
Bone Marrow Transplants: Cancer Drug Shows Promise Against Graft Vs. Host Disease in University of Michigan Study
July 17, 2008
 · 
1 min read
Drug Development
University of Edinburgh Case Points to Link Between Crohn’s Treatment, Cancer
July 17, 2008
 · 
1 min read
Drug Development
Wyeth (JOBS) and Amgen (JOBS): Trial Shows Combination Therapy Helps Arthritis
July 16, 2008
 · 
1 min read
Drug Development
Warfarin Safer than Heparin for Some Strokes, University of Texas Health Science Center Study Suggests
July 15, 2008
 · 
1 min read
Drug Development
Beta Blockers Help Hospitalized Heart Failure Patients, Data Presented in Journal of American College of Cardiology
July 14, 2008
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Ariad Pharmaceuticals, Inc. Stock Killed After FDA Places Trials of Inclusig on Hold; Stock Falls -65.99% at Market Close (October 9, 2013)
October 9, 2013
 · 
11 min read
Drug Development
Biogen Idec, Inc. (Massachusetts) Says Death of MS Patient Not Related to Drug
October 8, 2013
 · 
1 min read
Drug Development
Boehringer Ingelheim GmbH Release: Better Outcome in Case of Major Bleed for Patients Taking the Anticoagulant Pradaxa® Compared to Warfarin
October 7, 2013
 · 
1 min read
Drug Development
Biogen Idec, Inc. (Massachusetts)'s Hot New MS Drug Tecfidera Maintains Efficacy in Long-Term Study
October 4, 2013
 · 
9 min read
Drug Development
Biogen Idec, Inc. (Massachusetts) Release: New TYSABRI® Data Show Earlier Treatment and Longer-Term Use Result in Significant Reductions in MS Disease Activity
October 3, 2013
 · 
1 min read
Drug Development
Genzyme Corporation Release: Aubagio® Significantly Reduced Risk of New Clinical Relapse or MRI Lesion in Multiple Sclerosis Study
October 3, 2013
 · 
1 min read
Drug Development
Teva Pharmaceutical Industries Limited to Present Further Results of Twenty-Year Open-Label Extension Study of Glatiramer Acetate 20 mg Daily for Relapsing-Remitting Multiple Sclerosis
October 3, 2013
 · 
8 min read
Drug Development
Novo Nordisk A/S Study Shows Tresiba Efficacy for Diabetes
September 26, 2013
 · 
1 min read
Drug Development
Data Show Sanofi (France)'s Lyxumia® Added to Basal Insulin Lowered Blood Sugar Especially When Fasting Plasma Glucose Was Controlled
September 24, 2013
 · 
6 min read
Drug Development
Pacira Pharmaceuticals, Inc. Release: Study Shows EXPAREL® Provided Improved Pain Control, Shorter Length of Hospital Stay and Substantial Cost Savings Following Total Knee Replacement
September 20, 2013
 · 
1 min read
Drug Development
Repros Therapeutics Inc. Reports Preliminary Findings: Second Pivotal Study and 6-Month Safety Study Support Androxal® Approvability
September 17, 2013
 · 
1 min read
Drug Development
Boehringer Ingelheim Corporation, Pfizer Inc. Encounter Conflicting Data on Safety of Spiriva
September 11, 2013
 · 
1 min read
Drug Development
Roche’s Perjeta Works in Early-Stage Breast Cancer
September 10, 2013
 · 
1 min read
Drug Development
Boehringer Ingelheim GmbH’s Respimat Inhaler Meets Safety Goal in Study
September 3, 2013
 · 
1 min read
Drug Development
Boehringer Ingelheim Pharmaceuticals, Inc. Announces Plans to Expand Body of Evidence With Novel Cardiovascular Research Supporting Pradaxa® (dabigatran etexilate mesylate)
September 3, 2013
 · 
11 min read
Drug Development
AstraZeneca PLC, Bristol-Myers Squibb Company: New Diabetes Drug Onglyza Doesn’t Raise Heart Attack Risk
September 3, 2013
 · 
17 min read
Drug Development
FDA Probes Brain Infection in Patient on Novartis AG’s MS Drug
August 30, 2013
 · 
1 min read
Drug Development
Pfizer Inc. Completes Pneumococcal Pneumonia Case Accrual For CAPiTA, Adult Vaccine Clinical Trial of Prevenar 13*
August 29, 2013
 · 
1 min read
Drug Development
Allergan Inc. Demands the FDA Require Human Trials for Restasis Generics
August 21, 2013
 · 
1 min read
Drug Development
Orexo AB: First Patient Dosed in New Study on Long-Term Adherence to Treatment of Opioid Dependence With Zubsolv®
August 7, 2013
 · 
1 min read
Load More